Consumer group: FDA must ban Avandia because of health risks

10/30/2008 | Washington Post (tiered subscription model), The

Public Citizen, a consumer-advocacy group, called on the FDA to ban GlaxoSmithKline's Avandia because of life-endangering risks, including heart attack and liver failure, linked to the diabetes drug. The agency said it will "carefully review" the petition, which comes after the American Diabetes Association issued revised treatment guidelines that advise against Avandia.

View Full Article in:

Washington Post (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Litigation & Investigations EMEA
Gilead Sciences
Stockely Park
Assistant General Counsel/Senior Corporate Counsel
Genentech
South San Francisco, CA
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Alcon
Fort Worth, TX
Director, Senior Legal Counsel
Alcon
Fort Worth, TX